Drug Profile
Research programme: Alzheimer's disease therapies - Biogen
Alternative Names: Gamma secretase modulator - BiogenLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Biogen Idec
- Developer Biogen
- Class
- Mechanism of Action Amyloid precursor protein secretase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Alzheimer's-disease in Unknown
- 04 Feb 2011 Preclinical trials in Alzheimer's disease (unspecified route)